Diabetes Board decisions

The Board granted service connection for diabetes mellitus, type II, as the evidence established that the Veteran's diabetes had its onset within one year of service.

The Veteran's hypertension is being remanded for further review.,TDIU from June 17, 2021, to November 27, 2023, and as of April 18, 2024, are also being remanded for reconsideration.,As of April 18, 2024, the Veteran's TDIU is denied due to his ability to manage diabetes with oral medication.

The Board has granted an effective date of August 10, 2022 for the award of service connection for diabetic nephropathy and hypertension. The decision is based on the liberalizing law provided by the PACT Act which added hypertension to the list of diseases presumed related to exposure to herbicide agents.

The Veteran's diabetes mellitus, type I is granted a 60 percent evaluation from March 18, 2013 to February 1, 2019. Right and left lower extremity sciatica with diabetic peripheral neuropathy are each granted a 20 percent evaluation from April 5, 2022.

The Board has remanded the claims for sleep apnea and diabetes mellitus due to deficiencies in the medical opinions provided. Additional records, including SSA disability benefits records, need to be obtained and reviewed by a clinician.

The Veteran's service-connected disabilities do not prevent him from securing and following a substantially gainful occupation.

The Veteran's bilateral upper extremity and lower extremity diabetic neuropathy conditions are currently rated at the minimum level of disability, with no evidence of more severe symptoms warranting a higher rating.

The Veteran withdrew his appeal in its entirety prior to the promulgation of a decision.

The Board has remanded the claims for service connection due to a lack of information verifying exposure to herbicide agents during military service, and because the PACT Act requires VA to provide an examination and obtain a medical opinion addressing the possibility of a nexus between the claimed disabilities and the TERA.

The Board dismissed the appeals for service connection of hypertension and type II diabetes due to the Veteran's death.

The Board has granted service connection for diabetes mellitus, type II (DM), based on presumed exposure to Agent Orange while serving in Thailand.

The Board has determined that the Veteran's diabetes mellitus, type II is not service connected as there was no in-service exposure to herbicide agents and no evidence of a relationship between his current condition and his military service.

The Veteran's service-connected diabetic neuropathy of the left and right lower extremities involving the femoral nerve was denied evaluations in excess of 20 percent on or after April 13, 2022.

The Veteran's claim for a total disability rating based on individual unemployability (TDIU) is denied as there is no evidence showing he is precluded from obtaining and maintaining any form of gainful employment due to his service-connected disabilities.,The Veteran's claims for increased ratings for diabetes mellitus, type II and peripheral neuropathy are denied as the evidence does not support a finding that these conditions have worsened beyond what is already reflected in their current disability ratings.

The Veteran's claims for service connection for diabetes mellitus and prostate cancer are denied. The claim for diabetes mellitus is denied as there is no evidence of in-service exposure to an herbicide agent or treatment for meningitis that could have caused the current condition. The claim for prostate cancer is remanded due to insufficient information provided by the Veteran regarding his service.

The Board has granted service connection for diabetes mellitus type II, hypertension, peripheral neuropathy of the bilateral upper and lower extremities, and erectile dysfunction. The claims are based on direct evidence linking these conditions to the Veteran's service-connected diabetes mellitus type II.

The Veteran's diabetic retinopathy with dry eyes and cataract is granted a 20% rating effective March 6, 2020. The ratings for PTSD, Parkinson's disease, and malaria remain denied.

The Veteran's diabetes mellitus type II requires only a restricted diet and an oral glycemic agent, not requiring insulin or regulation of activities. Therefore, the claim for an initial rating in excess of 20 percent is denied.

The Veteran's service connection for diabetes mellitus, type II (DMII) is granted under the PACT Act due to presumed exposure in Guam. The claim of direct service connection remains pending.

The Veteran's claim for service connection for unspecified depressive disorder is granted. The claims for service connection for short term memory loss, gastroesophageal reflux disease (GERD), and diabetes mellitus type 2 (DM) are remanded.